Combination External Beam Radiation and Brachytherapy Boost With Androgen Suppression for Treatment of Intermediate-Risk Prostate Cancer: An Initial Report of CALGB 99809

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 3, 2008, Pages 814-819

  Hurwitz, Mark D ^a   Halabi, Susan ^b   Ou, San San ^c   McGinnis, Lamar S ^d   Keuttel, Michael R ^e   DiBiase, Steven J ^f   Small, Eric J ^g  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Southeast Cancer Control Consortium Winston   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brachytherapy; Brachytherapy boost; Clinical trial; Prostate; Radiation

Indexed keywords

POLARIZATION;

ANDROGEN SUPPRESSION; BRACHYTHERAPY; BRACHYTHERAPY BOOST; CLINICAL TRIAL; EXTERNAL BEAM RADIATION; EXTERNAL BEAM RADIATION THERAPY; HIGH-DOSE; PHASE II; PROSTATE; PROSTATE BRACHYTHERAPY; PROSTATE CANCER; RADIATION; SEMINAL VESICLES;

RISK ASSESSMENT;

ANTIANDROGEN; BICALUTAMIDE; FLUTAMIDE; GOSERELIN; IODINE 125; LEUPRORELIN; PALLADIUM 103;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; BLADDER SPASM; BRACHYTHERAPY; CANCER RISK; CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DYSURIA; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FLATULENCE; HOT FLUSH; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PELVIS PAIN SYNDROME; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTALGIA; PROCTITIS; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RISK ASSESSMENT; SEXUAL DYSFUNCTION; THROMBOSIS; URINARY FREQUENCY; URINE INCONTINENCE; URINE RETENTION; VASOMOTOR DISORDER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANDROGENS; BIOLOGICAL MARKERS; BRACHYTHERAPY; DOSE FRACTIONATION; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLADIUM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOISOTOPES; RADIOTHERAPY, CONFORMAL; SEMINAL VESICLES;

EID: 52949119554     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.010     Document Type: Article

References (20)

1. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response; results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol 53 (2002) 1097-1105
2. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled clinical trial. JAMA 294 (2005) 1233-1239
3. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
4. Kuban D., Pollack A., Huang E., et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 1260-1268
5. Zelefsky M., Cowen D., Fuks Z., et al. Long-term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate cancer. Cancer 85 (1999) 2460-2468
6. Ghaly M., Wallner K., Merrick G., et al. The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: Morbidity outcomes from two prospective randomized multicenter trials. Int J Radiat Oncol Biol Phys 55 (2003) 1288-1293
7. Singh A.M., Gagnon G., Collins B., et al. Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: Results of a matched pair analysis. Prostate 62 (2005) 54-60
8. Gelblum D.Y., Potters L., Ashley R., et al. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
9. Gelblum D.Y., and Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 119-124
10. Albert M., Tempany C.M., Schultz D., et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 98 (2003) 949-954
11. Kang S.K., Chou R.H., Dodge R.K., et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 53 (2002) 99-103
12. Sarosdy M.F. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Cancer 101 (2004) 754-760
13. Lee W.R., DeSilvio M., Lawton C., et al. A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate: Preliminary results of RTOG P-0019. Int J Radiat Oncol Biol Phys 64 (2006) 804-809
14. Lee W., Bae K., Lawton C., et al. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: Analysis of Radiation therapy Oncology Group study 0019. Cancer 109 (2007) 1506-1512
15. Keatng N.L., O'Malley A.J., and Smith M.R. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24 (2006) 4448-4456
16. Trotti A., Colevas A.D., Setser A., et al. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 32 (2007) 5121-5127
17. Benoit R., Naslund M., and Cohen J. Complications after prostate brachytherapy in the Medicare population. Urology 55 (2000) 91-96
18. Zelefsky M.J., Fuks Z., Wolfe T., et al. Locally advanced prostate cancer: Long-term toxicity outcome after three-dimensional conformal radiation therapy-a dose escalation study. Radiology 209 (1998) 169-174
19. Zelefsky M.J., Hollister T., Raben A., et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47 (2000) 1261-1266
20. Giordano S.H., Lee A., Kuo Y.-F., et al. Late gastrointestinal toxicity after radiation for prostate cancer. Cancer 107 (2006) 423-432